{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 4
    }
  },
  "results": [
    {
      "discontinued_date": "09/09/2026",
      "update_type": "New",
      "initial_posting_date": "09/09/2026",
      "package_ndc": "0006-3856-02",
      "generic_name": "Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection",
      "contact_info": "800-672-6372",
      "related_info": "To be discontinued on or near late September 2026.",
      "openfda": {
        "application_number": [
          "NDA212819"
        ],
        "brand_name": [
          "RECARBRIO"
        ],
        "generic_name": [
          "IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS"
        ],
        "manufacturer_name": [
          "Merck Sharp & Dohme LLC"
        ],
        "product_ndc": [
          "0006-3856"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "IMIPENEM ANHYDROUS",
          "CILASTATIN",
          "RELEBACTAM ANHYDROUS"
        ],
        "rxcui": [
          "2184142",
          "2184147"
        ],
        "spl_id": [
          "11f74255-d000-4759-a561-136a5f13f667"
        ],
        "spl_set_id": [
          "be32f468-738b-40df-a425-591e12f65159"
        ],
        "package_ndc": [
          "0006-3856-01",
          "0006-3856-02"
        ],
        "nui": [
          "M0024174",
          "N0000175496",
          "N0000175513",
          "N0000175514",
          "N0000175930",
          "N0000000202"
        ],
        "pharm_class_cs": [
          "Carbapenems [CS]"
        ],
        "pharm_class_epc": [
          "Penem Antibacterial [EPC]",
          "Renal Dehydropeptidase Inhibitor [EPC]",
          "beta Lactamase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Dipeptidase Inhibitors [MoA]",
          "beta Lactamase Inhibitors [MoA]"
        ],
        "unii": [
          "Q20IM7HE75",
          "141A6AMN38",
          "1OQF7TT3PF"
        ]
      },
      "update_date": "09/09/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "dosage_form": "Injection",
      "presentation": "RECARBRIO, Injection, 500 mg/100 mL; 500 mg/100 mL; 250 mg/100 mL (NDC 0006-3856-02)",
      "company_name": "Merck Sharp & Dohme LLC",
      "status": "To Be Discontinued"
    }
  ]
}